Abstract:Main Points R47H TREM2 variant, linked to Alzheimer's disease, increases neuronal loss and microglial phagocytosis likely via increased activation by phosphatidylserine. TREM2 increases cystatin F expression which inhibits general microglial phagocytosis. Triggering receptor on myeloid cells 2 (TREM2) is an innate immune receptor, upregulated on the surface of microglia associated with amyloid plaques in Alzheimer's disease (AD). Individuals heterozygous for the R47H variant of TREM2 have greatly increased risk of developing AD. We examined the effects of wild‐type (WT), R47H and knock‐out (KO) of human TREM2 expression in three microglial cell systems. Addition of mouse BV‐2 microglia expressing R47H TREM2 to primary mouse neuronal cultures caused neuronal loss, not observed with WT TREM2. Neuronal loss was prevented by using annexin V to block exposed phosphatidylserine, an eat‐me signal and ligand of TREM2, suggesting loss was mediated by microglial phagocytosis of neurons exposing phosphatidylserine. Addition of human CHME‐3 microglia expressing R47H TREM2 to LUHMES neuronal‐like cells also caused loss compared to WT TREM2. Expression of R47H TREM2 in BV‐2 and CHME‐3 microglia increased their uptake of phosphatidylserine‐beads and synaptosomes versus WT TREM2. Human iPSC‐derived microglia with heterozygous R47H TREM2 had increased phagocytosis of synaptosomes vs common‐variant TREM2. Additionally, phosphatidylserine liposomes increased activation of human iPSC‐derived microglia expressing homozygous R47H TREM2 versus common‐variant TREM2. Finally, overexpression of TREM2 in CHME‐3 microglia caused increased expression of cystatin F, a cysteine protease inhibitor, and knock‐down of cystatin F increased CHME‐3 uptake of phosphatidylserine‐beads. Together, these data suggest that R47H TREM2 may increase AD risk by increasing phagocytosis of synapses and neurons via greater activation by phosphatidylserine and that WT TREM2 may decrease microglial phagocytosis of synapses and neurons via cystatin F.

AD-linked R47H- TREM2 mutation induces disease-enhancing microglial states via AKT hyperactivation

AD-linked R47H- TREM2 mutation induces disease-enhancing proinflammatory microglial states in mice and humans

AD-linked R47H-<i>TREM2</i>mutation induces disease-enhancing proinflammatory microglial states in mice and humans

TREM2 drives microglia response to amyloid-β via SYK-dependent and -independent pathways

TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy

TREM2 Modifies Microglial Phenotype and Provides Neuroprotection in P301S Tau Transgenic Mice.

Alzheimer's disease‐associated R47H TREM2 increases, but wild‐type TREM2 decreases, microglial phagocytosis of synaptosomes and neuronal loss

Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease

TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models

TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration

Opposing Roles of the Triggering Receptor Expressed on Myeloid Cells 2 and Triggering Receptor Expressed on Myeloid Cells-Like Transcript 2 in Microglia Activation.

Soluble TREM2 Induces Inflammatory Responses and Enhances Microglial Survival

TREM2 Inhibits Tau Hyperphosphorylation and Neuronal Apoptosis via the PI3K/Akt/GSK-3β Signaling Pathway In vivo and In vitro

Activation of FAK/Rac1/Cdc42‐GTPase Signaling Ameliorates Impaired Microglial Migration Response to Aβ42in Triggering Receptor Expressed on Myeloid Cells 2 Loss‐of‐function Murine Models

Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer’s disease

TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease

Silencing of TREM2 Exacerbates Tau Pathology, Neurodegenerative Changes, and Spatial Learning Deficits in P301S Tau Transgenic Mice

Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models

TREM2-Dependent Effects on Microglia in Alzheimer's Disease

Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer’s disease model

Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer's disease.